A Randomized, Single Blind Trial to Assess the Effectiveness of Maintaining Patency and Safety of the Vascular Wrap Paclitaxel-Eluting Mesh After Surgical Implantation With the Lifespan ePTFE [expanded polytetrafluoroethylene] Vascular Graft in the Upper Extremity for Hemodialysis Vascular Access.

A Randomized, Single Blind Trial to Assess the Effectiveness of Maintaining Patency and Safety of the Vascular Wrap Paclitaxel-Eluting Mesh After Surgical Implantation With the Lifespan ePTFE [expanded polytetrafluoroethylene] Vascular Graft in the Upper Extremity for Hemodialysis Vascular Access.

Discontinued

Phase of Trial:
Phase III

Latest Information Update:16 Nov 2011

At a glance

Drugs
Paclitaxel (Primary)

Indications
Thrombosis

Focus
Therapeutic Use

Sponsors
Angiotech Pharmaceuticals

Most Recent Events

16 Nov 2011
Status changed from completed to discontinued as reported by ClinicalTrials.gov.

22 Sep 2009
Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

31 Jul 2008
The expected completion date for this trial is now 1 Apr 2009 as reported by ClinicalTrials.gov.

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login
with a username/password associated to an account with a valid subscription